Oncology Hematology Care, Inc.

06/18/2024

Receiving a cancer diagnosis is a life-altering moment that can leave patients and their loved ones feeling overwhelmed and uncertain about the next steps. In such critical times, seeking a second opinion from another expert may provide clarity, confidence, and potentially life-saving insights. Over the past 40 years, countless patients have sought OHC’s advice, and guidance through a second opinion. Read our newest blog to understand why some patients may request a second opinion and how OHC is here to help you ensure you are receiving the best possible treatment plan https://ohcare.com/patients-choose-ohc-second-opinion/

06/17/2024

The OHC Genetic Risk Evaluation and Testing Program (GREAT) provides testing and counseling for people who may be at risk for hereditary cancer. Elizabeth Burneka, MSN, APRN, AOCNP, is on the genetics team and explains the process for those eligible.

“Our team helps those at-risk make informed decisions about their healthcare needs. We will determine your eligibility first with a comprehensive personal and family history. Depending on your history, cancer genetic testing may be ordered. Our genetics specialists will go over the results with you and if you are found to have a positive genetic link to cancer, we will provide you with an individualized care plan that could include surveillance, risk-reduction medications, or preventative surgery.

A positive genetics diagnosis will also include identifying those family members who may need to be informed. We offer free cancer genetics testing to your immediate family members living locally, if you test positive.

Genetic testing is useful in helping to make educated choices about your future. In a way, it serves as a road map to risk reduction. It is also important to understand that a positive result does not mean you WILL be diagnosed with cancer. It simply means we need to take steps going forward to help reduce risk and evaluate with screenings to find things sooner rather than later.”

To learn more about the OHC GREAT Program, please visit ohcare.com. You do not have to be an OHC patient to be seen by our genetics specialists.

06/14/2024

To OHC patient Douglas Dick, his family means everything. That's why he never lost hope when he was diagnosed with HPV-related head and neck cancer in 2019. Five years later, Doug shares his story of resilience to provide others like him hope for their own future. Read Doug's inspiring and heartwarming story here https://ohcare.com/ohc-patient-grateful-time-family/

06/13/2024

OHC doctors and advanced practice providers recently attended the APP Oncology Summit. OHC had a large presence at the conference, with presentations by Dr. Ajit Gubbi, Dr. David Waterhouse, APP Tiffany Jones, and APP Lisa Ovesen, while OHC's Director of Clinical Services, Aimee Brown, was a member of the Planning Committee.

It was a big moment for OHC APP Tiffany Jones, who was awarded Cincinnati's APP MVP! Congratulations to Tiffany and the other members of the OHC team who represented our organization at this important conference focusing on sharing the latest evidence-based strategies to optimize care and outcomes for patients with cancer.

06/13/2024

Today marks the beginning of the 4th Annual National Black Family Cancer Awareness Week. African Americans have a higher risk of several cancers and this week is designed to increase cancer awareness in this vulnerable community. Be sure to watch the video for what you can do to increase your awareness.

OHC shared a blog in February detailing the types of cancers African Americans are more likely to be diagnosed with, risk factors, and what you can do to reduce your risk: https://ohcare.com/addressing-cancer-risks-black-community/

06/12/2024

Kruti Patel, DO, is a highly skilled member of the OHC blood cancer team. Dr. Patel is a board-certified hematologist, medical oncologist, and blood and marrow transplant (BMT) expert. She specializes in malignant hematology, clinical research, and BMT. She also serves as the principal investigator for myeloma, leukemia, and BMT clinical trials, and Associate Director of the Cincinnati Center for Cellular Therapy at The Jewish Hospital-Mercy Health.

Dr. Patel's patient care philosophy is centered on providing compassionate care. "It truly is an honor to care for a patient fighting cancer," she says. "There can be a lot of ups and downs throughout a patient's journey, and I have the opportunity to hold their hands and walk with them as they navigate their disease. I care for my patients as if they were my own family members."

To learn more about Dr. Patel, or to schedule an appointment or second opinion, visit ohcare.com.

06/11/2024

For this National Cancer Survivors Month, OHC would like to introduce a few helpful tips for incorporating integrative medicine into the healing process, specifically for stress reduction. An individual is considered a cancer survivor from the time of diagnosis through the balance of his/her life. To help patients, their families, and caregivers, read our new blog from OHC radiation oncologist and integrative medicine specialist John F. Sacco, MD. https://ohcare.com/how-to-survive-stress/

06/10/2024

In honor of Men's Health Week, OHC would like to highlight several ways to reduce your risk for common health issues and cancers that affect men. By modifying your dietary choices, following an exercise routine, knowing your family history, and avoiding smoking and risky behavior, you can help reduce your chances of being diagnosed with certain cancers. See our video below to learn more about what you can do.

06/07/2024

When most people think of breast cancer, they imagine it affecting older women. However, an alarming trend shows an increase in women under 40 being diagnosed at a higher rate than was previously seen. For women like OHC patient Rebecca Davis, who was only 29 when she was diagnosed, and with no family history of breast cancer or related cancers, it was the last thing she expected. Read her story: https://ohcare.com/ohc-helps-new-mother-navigate-breast-cancer/

06/06/2024

June is Cancer Immunotherapy Month and OHC advanced practice provider Emma Shaffer, MPAS, PA-C explains what immunotherapy is and how it is used to treat cervical cancer.

“Cancer grows by hiding from your immune system, which is designed to attack foreign cells or infection to keep you healthy. Cancer can actually trick your immune system into not just ignoring it, but potentially even defending it. Immunotherapies are medications that help boost your immune system to fight cancer more effectively. Some work by blocking specific proteins in your immune system to engage your immune response towards the cancer cells. Pembrolizumab is a leading immunotherapy we use to treat cervical cancer, often along with chemotherapy, depending on the patient’s specific diagnosis. It’s given through an IV every three to six weeks and has had success in providing better patient outcomes with fewer side effects.”

To learn more about immunotherapy, schedule an appointment, or to request a second opinion, visit ohcare.com.

06/04/2024

There are an estimated 18 million people in the U.S. who are living with cancer. This June, in honor of Cancer Survivor Awareness Month, we celebrate those who have beaten cancer and can give hope to the thousands of people in our region who will be diagnosed each year. Please share your stories in the comments below so that others may be inspired by your journey and feel hopeful for the path they are starting.

If you have been recently diagnosed with cancer, please call us at 888.649.4800 or visit ohcare.com to schedule an appointment with one of our cancer experts.

05/30/2024

Colorectal cancer is the third-leading cause of cancer deaths in men and the fourth-leading cause in women in the United States. OHC is dedicated to the fight against this widespread cancer and is proud to announce its participation in a vital clinical trial for a novel colorectal cancer vaccine, (RO7198457), offering this groundbreaking option to a select group of patients. OHC medical oncologist and hematologist Mark E. Johns, MD, helps explain the significance of this trial and who is eligible - https://ohcare.com/colorectal-cancer-patients-ohc-joins-groundbreaking-vaccine-trial/

OHC is the region's premier provider of treatment for adult cancers and blood disorders. Cincinnati,

05/30/2024

Thank you, Liz Bonis Local 12 News, for the opportunity to discuss this recent study about tattoos and their possible connection to lymphoma cases. OHC medical oncologist and hematologist Dr. Randy Drosick explains why it's important to stay informed when choosing to get a tattoo.

A new report is now raising concerns about tattoos and a possible connection to cancer. Now oncologists are sharing what they want others to know.

05/29/2024

As we begin to enjoy the summer weather, OHC would like to remind you how to reduce your risk of skin cancer. Watch our video to learn the risk factors and tips you can follow to practice sun safety. To learn more about skin cancer, visit https://ohcare.com/condition/skin-cancer/

05/27/2024

Today we honor and remember those who fought for our country and gave their lives for our freedom. Your sacrifice will never be forgotten.

05/24/2024

Cancer Support Community Greater Cincinnati-Northern Kentucky (CSC) is a local organization focused on providing support to anyone affected by cancer so that no one faces cancer alone.

Each month, CSC provides free in-person and remote classes, support groups, social gatherings, and lectures to help educate and support cancer patients, their families, and caregivers. Together with CSC, OHC is dedicated to providing compassionate care, resources, and a supportive environment, to help improve the quality of life of patients living with cancer.

If you are interested in learning more about the offerings and support provided by CSC, please visit mycancersupportcommunity.org to learn more.

05/24/2024

OHC celebrated our newest DAISY Foundation Award winner, Jasmine Platt, RN, last week during National Nurses Week. Jasmine, an OHC float treatment suite nurse, was nominated by a patient from the OHC West office for her exceptional skill and compassionate care. Read the patient's nomination and meet the other nurses nominated for the second round of DAISY Awards from 2023: https://ohcare.com/ohc-celebrates-nurse-excellence-jasmine-platt-receives-daisy-award/

05/23/2024

OHC patient Sandy Hunt is living proof of how a second opinion led her to a clinical trial that offered her hope and a possible new treatment for other patients with Mantle Cell Lymphoma. MCL is an aggressive blood cancer that cannot be cured. Instead, patients typically experience a never-ending cycle of treatment, remission, relapse. However, through the cancer research and clinical trials program at OHC, Sandy participated in a clinical trial that provided her with what she wanted: more time. Read about Sandy's incredible story and the importance of clinical trials in our newest blog. https://ohcare.com/crucial-second-opinion-leads-clinical-trial-remission/

05/22/2024

OHC is delighted to introduce our newest Advanced Practice Provider, Kate Bills, MPAS, PA-C. After working with cancer patients as a research assistant and then patient care associate, Kate felt a calling to the field of cancer. “I was inspired by the strength and resiliency of the patients I cared for, and I wanted to be a part of the team that supported them.”

Kate believes in being an advocate for her patients. “Focusing on being thorough, I make sure my patients know they are a valued member of the team. I want them to take an active role, expressing their thoughts and questions they may have.”

Kate enjoys spending time with her family and pets, as well as traveling and reading. She will be working with patients at our OHC Eastgate location. To schedule an appointment or to request a second opinion, please call 1-888-649-4800 or visit ohcare.com.

05/21/2024

To highlight Cancer Research Month, OHC medical oncologist and hematologist David M. Waterhouse, MD, MPH, was a special guest on The Brian Thomas Show on 55KRC Radio this morning. He discussed our collaboration with Sarah Cannon Research Institute (SCRI) and the importance of clinical trials. https://www.spreaker.com/episode/brian-interviews-ohc-dr-waterhouse-cancer-research-month--60111949

To see our full list of clinical trials offerings or to request a second opinion with one of our region’s leading cancer experts, call 1-888-869-4800 or visit https://ohcare.com/.

05/21/2024

OHC would like to congratulate Evan Z. Lang, MD, MS, for his recent publication in Blood Reviews, a respected international journal, titled “Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances,” in collaboration with Frits van Rhee, MD, PhD, a leading researcher on Castleman Disease. Read more about Dr. Lang's publication and work here: https://ohcare.com/ohc-leading-expert-publishes-rare-condition/

05/17/2024

OHC was proud to attend this year's Light The Night Cincinnati Leadership Breakfast held by The Leukemia & Lymphoma Society - Ohio River Valley. Thank you LLS for hosting a wonderful event with a great mission focused on funding blood cancer research. Liz Bonis Local 12 News did a fantastic job as emcee and interviewed OHC hematologist, medical oncologist, and cellular therapy expert Dr. Akash Mukherjee on the advancements made at OHC in treating blood cancers. We look forward to helping LLS raise money for their annual Light The Night event!

The local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for blood cancer research, and it’s giving patients new hope.

05/17/2024

A cancer diagnosis for older patients often raises unique challenges due to the potential side effects and tolerance for certain treatments such as chemotherapy. With many types of cancer, however, chemotherapy may be the only treatment option, until now. OHC's cancer research and clinical trials program offers a beacon of hope by exploring an innovative therapy for elderly lymphoma patients, potentially maintaining their quality of life while fighting the disease. Read about OHC patient Vanetta Kelly in our newest blog: https://ohcare.com/promising-clinical-trial-for-elderly-patients/

05/16/2024

In recognition of National Cancer Research Month, OHC medical oncologist, hematologist, and Director of Early Phase Trials David M. Waterhouse, MD, MPH, will be a guest on the Brian Thomas Show on 55KRC Radio Tuesday, May 21 at 8:30am. Dr. Waterhouse will share more on the OHC collaboration with Sarah Cannon Research Institute (SCRI), as well as explain the importance of clinical trials. Be sure to tune in!

05/15/2024

OHC is proud to announce our collaboration with Sarah Cannon Research Institute (SCRI), a leader in community-based cancer clinical trials!

Through SCRI at OHC, patients will have access to more cutting-edge research and potential treatment options.

Learn more at https://ohcare.com/ohc-announces-collaboration-sarah-cannon-research-institute/

05/14/2024

OHC medical oncologist and hematologist David M. Waterhouse, MD, MPH is a respected expert in the field of oncology. His passion for cancer research and improving patient outcomes drives him to continue pushing for more advanced cancer treatments. He has been recognized by his peers through various awards, but his biggest and most valued supporters are his patients. You only need to read a few to understand his commitment to them:

“I had an amazing experience with Dr. Waterhouse!! I always felt HEARD about my concerns and he made sure I always had a good understanding of what was going on. Happy to have him as my doctor!!” M.D., Google

“He listened to all my concerns and helped me choose the right course of treatment since I had more than one treatment option. He really cares about his patients. I can't recommend Dr Waterhouse highly enough.” Anonymous, Healthgrades

“Genuinely one of the nicest doctors I’ve ever been to. You can tell he cares about his patients and loves his job.” A.H., Google

To schedule an appointment or request a second opinion with Dr. Waterhouse, please call 888-649-4800 or visit ohcare.com today.

05/14/2024

"As cancer doctors, we know early detection plays a crucial role in successful treatment and better outcomes for women, making it essential to recognize and act upon potential warning signs early on. That being said, not all cancers present with early signs and symptoms. Paying attention to your body and knowing what is normal for you so you can report anything that seems unusual is very important," states OHC gynecologic oncologist Marcia C. Bowling, MD. In honor of Women's Health Week, Dr. Bowling explains in her recent blow the symptoms of gynecologic cancers and what you can do to reduce your risk. Read it here: https://ohcare.com/gynecologic-cancer-symptoms-shouldnt-ignore/

OHC is the region's premier provider of treatment for adult cancers and blood disorders. Cincinnati,

05/13/2024

According to the American Cancer Society, over 18,000 people will die from brain and spinal cord tumors each year. While your risk of being diagnosed with brain tumors is low, it’s important to know your treatment options and where to go if the unthinkable happens.

At OHC, our multi-disciplinary team of cancer experts creates personalized and targeted treatment plans that are intended to provide you with the best possible outcome and quality of life during treatment. A vital tool in our toolkit is Gamma Knife Radiosurgery.

Despite its name, the Gamma Knife procedure is a painless non-invasive form of radiation therapy with minimal risks and side effects to prolong a patient's lifespan and improve quality of life. It does this by using highly focused gamma X-rays to precisely target tumors and lesions while sparing radiation to the surrounding healthy brain.

OHC is the only provider in the region to offer this advanced treatment option and has highly skilled radiation oncologists on our team who are experts in Gamma Knife Radiosurgery. Those experts include Imran H. Chowdhury, MD, Courtney L. Hentz, MD, Marc R. Mosbacher, MD, and Rahul N. Prasad, MD, MBA.

To learn more about Gamma Knife Radiosurgery, brain tumors, and our expert doctors, visit ohcare.com.

05/10/2024

A final thank you to our OHC nurses during Nurses Week. We are truly appreciative of your dedication, compassion, kindness, and thoughtfulness to our patients. From what you have seen this week, your hard work does not go unnoticed. Here are just a few photos of our incredible OHC nurses!

05/10/2024

OHC is currently one of only 37 sites in the country offering access to the groundbreaking Phase 3 clinical trial evaluating a novel HER2-positive breast cancer vaccine, GLSI-100 (GP2 + GM-CSF). This unique trial represents a significant step forward in the fight against recurrence and underscores OHC’s commitment to offering our patients innovative and potentially life-saving solutions. Dr. Roma Srivastava is the principal investigator on this revolutionary trial and she discusses the importance of this study in our latest blog: https://ohcare.com/ohc-offers-groundbreaking-breast-cancer-vaccine-trial/